13D/13G Filings - SILEXION THERAPEUTICS CORP (SLXNW)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-10
5:31 pm
Purchase
2024-12-3113GBiomotion Sciences Ordinary Shares
SLXN
GOLDMAN SACHS GROUP INC
GS
112,242
6.600%
112,242increase
(New Position)
Filing
History
2025-01-23
12:19 pm
Purchase
2025-01-1513GBiomotion Sciences Ordinary Shares
SLXN
CVI Investments, Inc.339,000
8.500%
339,000increase
(New Position)
Filing
History
2025-01-21
5:49 pm
Purchase
2025-01-1513GBiomotion Sciences Ordinary Shares
SLXN
Mitchell P. Kopin209,827
4.990%
209,827increase
(New Position)
Filing
History
2024-11-20
06:15 am
Purchase
2024-08-1513DBiomotion Sciences Ordinary Shares
SLXN
Guangzhou Sino-Israel Bio-Industry Investment Fund LLP220,787
13.800%
220,787increase
(New Position)
Filing
History
2024-08-22
6:44 pm
Purchase
2024-08-1513DBiomotion Sciences Ordinary Shares
SLXN
Wildcat Capital Management LLC113,428
10.500%
113,428increase
(New Position)
Filing
History
2024-08-22
5:23 pm
Purchase
2024-08-1513DBiomotion Sciences Ordinary Shares
SLXN
Moringa Sponsor LP229,623
20.800%
229,623increase
(New Position)
Filing
History